Nature MedicineScore8.5
KRAS G12C resistance via Y96D in non-small cell lung cancer
A multicenter cohort describes Y96D as a KRAS G12C inhibitor resistance mechanism with direct therapeutic implications.
- Date
- May 20, 2026
- Genes
- KRAS, STK11
Public bulletin
Published articles, channel scores and biological entities, ready to scan every week.
Weekly selection
2 articlesNature Medicine · KRAS, STK11
Genome Medicine · TP53, EGFR, BRAF
2 articles
A multicenter cohort describes Y96D as a KRAS G12C inhibitor resistance mechanism with direct therapeutic implications.
Independent benchmark of graph models for somatic variant interpretation, with public validation sets and error analysis.
3 articles
Preprint describing single-cell trajectories associated with mutant ESR1 in hormone-sensitive breast cancer.